[go: up one dir, main page]

ECSP12011991A - OXINTOMODULIN PEPTIDE ANALOG - Google Patents

OXINTOMODULIN PEPTIDE ANALOG

Info

Publication number
ECSP12011991A
ECSP12011991A ECSP12011991A ECSP12011991A EC SP12011991 A ECSP12011991 A EC SP12011991A EC SP12011991 A ECSP12011991 A EC SP12011991A EC SP12011991 A ECSP12011991 A EC SP12011991A
Authority
EC
Ecuador
Prior art keywords
peptide analog
oxintomodulin peptide
oxintomodulin
obesity
diabetes
Prior art date
Application number
Other languages
Spanish (es)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ECSP12011991A publication Critical patent/ECSP12011991A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a un análogo peptídico de Oxintomodulina empleado en el tratamiento de diabetes y/u obesidad.The present invention relates to an oxintomodulin peptide analog used in the treatment of diabetes and / or obesity.

ECSP12011991 2009-12-22 2012-06-20 OXINTOMODULIN PEPTIDE ANALOG ECSP12011991A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28888809P 2009-12-22 2009-12-22
US201031352576 2010-06-08

Publications (1)

Publication Number Publication Date
ECSP12011991A true ECSP12011991A (en) 2012-07-31

Family

ID=52633930

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP12011991 ECSP12011991A (en) 2009-12-22 2012-06-20 OXINTOMODULIN PEPTIDE ANALOG

Country Status (1)

Country Link
EC (1) ECSP12011991A (en)

Similar Documents

Publication Publication Date Title
CR20120338A (en) OXINTOMODULIN PEPTIDE ANALOG
ECSP12011988A (en) OXINTOMODULIN PEPTIDE ANALOG
PT2503892T (en) USE OF THE FUNGIC ORGANISM PYTHIUM OLIGANDRUM
CL2012003026A1 (en) Pharmaceutical composition comprising pioglitazone and linagliptin; preparation procedure; Use in the treatment of type 2 diabetes or obesity.
PH12012500632B1 (en) Pharmaceutical compositions comprising bi-1356 and metformin
BRPI0813139A2 (en) GLP-1 PEPTIDE WITH ADDITION OF AN OLIGOSACARIDE CHAIN
BRPI1007339A2 (en) MEDICAL DEVICES AND METHODS
EP2408921A4 (en) MODIFICATION OF CXCR4 WITH MANIPULATED ZINC FINGER PROTEINS
BR112012010923A2 (en) bifidobacterium strain
GT200800046S (en) CONTAINER IN FORM OF ONION
BR112012001484A2 (en) lighting device and display device.
CR20120035A (en) COMBINATORY THERAPY OF AN ANTIBODY ANTI-CD20 AFUCOSILATED WITH FLUDARABINE AND / OR MITOXANTRONE
UA108636C2 (en) PEPTIDE
EA201290542A1 (en) MODIFIED PORK SOMATOTROPINE POLYPEPTIDES AND THEIR APPLICATION
UY34575A (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF DIABETES AND / OR OBESITY
PL2464656T3 (en) Novel peptide and use thereof
EP2478010A4 (en) PARTIAL PEPTIDE OF LACRITIN
ES2663096T3 (en) Methods for the treatment of nephrotic syndrome and related conditions
BR112012033045A2 (en) treatment of vascular complications of diabetes.
ECSP12011991A (en) OXINTOMODULIN PEPTIDE ANALOG
DOP2016000096A (en) NEW COMPOUND FOR THE TREATMENT OF SEVERE HYPOGLYCEMIA
CL2012000355A1 (en) Compounds derived from 4-amino-butenamide; pharmaceutical composition; and use in the treatment of COPD.
UA106465C2 (en) Oxyntomodulin peptide analogue
PH12012501264A1 (en) Oxyntomodulin peptide analogue
CY1115268T1 (en) ANTI-OXIDOMONTOULINE PIPE